MiR-17-92 enriched exosomes derived from multipotent mesenchymal stromal cells enhance axon-myelin remodeling and motor electrophysiological recovery after stroke

J Cereb Blood Flow Metab. 2021 May;41(5):1131-1144. doi: 10.1177/0271678X20950489. Epub 2020 Aug 18.

Abstract

MiR-17-92 cluster enriched exosomes derived from multipotent mesenchymal stromal cells (MSCs) increase functional recovery after stroke. Here, we investigate the mechanisms underlying this recovery. At 24 h (h) post transient middle cerebral artery occlusion, rats received control liposomes or exosomes derived from MSCs infected with pre-miR-17-92 expression lentivirus (Exo-miR-17-92+) or control lentivirus (Exo-Con) intravenously. Compared to the liposomes, exosomes significantly reduced the intracortical microstimulation threshold current of the contralateral cortex for evoking impaired forelimb movements (day 21), increased the neurite and myelin density in the ischemic boundary area, and contralesional axonal sprouting into the caudal forelimb area of ipsilateral side and in the denervated spinal cord (day 28), respectively. The Exo-miR-17-92+ further enhanced axon-myelin remodeling and electrophysiological recovery compared with the EXO-Con. Ex vivo cultured rat brain slice data showed that myelin and neuronal fiber density were significantly increased by Exo-miR-17-92+, while significantly inhibited by application of the PI3K/Akt/mTOR pathway inhibitors. Our studies suggest that the miR-17-92 cluster enriched MSC exosomes enhanced neuro-functional recovery of stroke may be attributed to an increase of axonal extension and myelination, and this enhanced axon-myelin remodeling may be mediated in part via the activation of the PI3K/Akt/mTOR pathway induced by the downregulation of PTEN.

Keywords: axon-myelin unit; exosome; miR-17-92 cluster; motor electrophysiological recovery; stroke.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Administration, Intravenous
  • Animals
  • Axons / metabolism
  • Down-Regulation
  • Electrophysiological Phenomena / genetics
  • Exosomes / metabolism
  • Infarction, Middle Cerebral Artery / complications
  • Infarction, Middle Cerebral Artery / metabolism*
  • Liposomes / metabolism
  • Male
  • Mesenchymal Stem Cell Transplantation / adverse effects
  • Mesenchymal Stem Cells / metabolism*
  • MicroRNAs / administration & dosage
  • MicroRNAs / genetics*
  • MicroRNAs / metabolism
  • Models, Animal
  • Myelin Sheath / metabolism
  • Neurites / physiology
  • Neurogenesis / genetics
  • Neurogenesis / physiology*
  • Neuronal Plasticity / physiology
  • Neurons / cytology
  • Neurons / metabolism*
  • Neurons / ultrastructure
  • PTEN Phosphohydrolase / metabolism
  • Phosphatidylinositol 3-Kinases / metabolism
  • Phosphoinositide-3 Kinase Inhibitors
  • Rats
  • Rats, Wistar
  • Recovery of Function / physiology
  • Stroke / physiopathology*
  • TOR Serine-Threonine Kinases / antagonists & inhibitors

Substances

  • Liposomes
  • MIRN17 microRNA, rat
  • MicroRNAs
  • Phosphoinositide-3 Kinase Inhibitors
  • mTOR protein, rat
  • TOR Serine-Threonine Kinases
  • PTEN Phosphohydrolase
  • PTEN protein, human